跳至主要内容
临床试验/CTRI/2020/04/024768
CTRI/2020/04/024768尚未招募未知

Role of Melatonin in re-establishment of nocturnal dip of blood pressure in patients with hypertension: a randomized controlled trial. - NBPD-M

Centre for integrative Medicine and Research0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients diagnosed with Hypertension.
  • On stable antihypertensive medication for 6 weeks before trial enrollment.
  • Non-dipping Blood pressure profile (>= 10% dipping of blood pressure at night in comparison of day on mean arterial blood pressure): On Ambulatory blood pressure monitoring.

排除标准

  • Patients with accelerated hypertension (Stage III).
  • Patients with secondary hypertension: Renal disease, Endocrinopathies.
  • Patients with history of target organ damage (Nephropathy, Retinopathy).
  • Patients with other cardiac disorders Example: Heart failure (EF <50%), congenital cardiac heart disease, atrial fibrillation infection.
  • Major Stroke or recent stroke.
  • Patients on the drug interacting with Melatonin.
  • Circadian rhythm sleep wake disorders (DSPS, ASPS, Shift workers)
  • No acute coronary syndrome (PCI and CABg) with in 3 Month.
  • Major depressive disorder on medication.

研究者

发起方
Centre for integrative Medicine and Research

相似试验